APA (7th ed.) Citation

G, B., CG, C., D, M., F, M., M, M., D, P., . . . F, P. (2026). Impact of cladribine tablets on PROs in patients with MS: Insights from the 1st interim analysis of the CLADFIT-MS study. Frontiers in neurology, 17, 1765153. https://doi.org/10.3389/fneur.2026.1765153

Chicago Style (17th ed.) Citation

G, Borriello, Chisari CG, Maimone D, Matta F, Mirabella M, Paolicelli D, Assogna F, Caradonna S, and Patti F. "Impact of Cladribine Tablets on PROs in Patients with MS: Insights from the 1st Interim Analysis of the CLADFIT-MS Study." Frontiers in Neurology 17 (2026): 1765153. https://doi.org/10.3389/fneur.2026.1765153.

MLA (9th ed.) Citation

G, Borriello, et al. "Impact of Cladribine Tablets on PROs in Patients with MS: Insights from the 1st Interim Analysis of the CLADFIT-MS Study." Frontiers in Neurology, vol. 17, 2026, p. 1765153, https://doi.org/10.3389/fneur.2026.1765153.